Our finding revealed a non-enzymatic role of PSAT1, in which PSAT1 might be essential for metabolic rerouting during tumor cell metastasis, and targeting PSAT1 may hold the potential to benefit tumor treatment by inhibiting mitochondrial metabolism. This evidence concerns the gene PSAT1 and neoplasm.